AliveCor Expands AI Cardiac ECG Technology in Vietnam
MOUNTAIN VIEW, Calif., April 07, 2026 AliveCor Inc., a global leader in AI-powered cardiology solutions, has announced the regulatory...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MOUNTAIN VIEW, Calif., April 07, 2026 AliveCor Inc., a global leader in AI-powered cardiology solutions, has announced the regulatory...
OMER, Israel & LOS ANGELES, Feb. 2, 2026 — Pulsenmore Ltd., a pioneer in home-use ultrasound and remote prenatal...
